Jeff Jonas, an analyst at Gabelli & Co., says he recommends shares of Bristol-Myers Squibb and Watson Pharmaceuticals. Jonas talks with Bloomberg's Ken Prewitt, Tom Keene and Sara Eisen on Bloomberg Radio's "Bloomberg Surveillance."
Energy Future Holdings Corp., the bankrupt Texas power provider, agreed to delay until June 30 a court fight over a restructuring agreement it struck with some creditors before filing for bankruptcy last month.
Johnson & Johnson , the world’s second-biggest seller of health products, increased its annual earnings forecast after quarterly profit beat estimates on drug sales and a weak dollar. The shares rose the most since 2008.